Abeona Therapeutics Inc. ABEO
Set alert
4.25 USD -0.10 -2.30%
At close
4.25 0.00 +0.00%
Pre-market · Nov 3, 7:04 AM ET
4.16 Day range 4.46
4.00 52-week range 7.65
- YTD
- -19.35%
- 1 year
- -11.64%
- Open
- 4.43
- Prev close
- 4.35
- Mkt cap
- 243.03M
- Vol
- 1.01M
- Avg vol
- 1.35M
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.16
- High
- 4.46
- Forward P/E
- -3.84
- Beta
- 1.50
- Short ratio
- 10.79
- Inst. own
- 77.54%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.15
- 200-d avg
- 5.64
- 1y target
- 16.75
3M chart
Signals (9)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 6 days ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| RSI: Overbought | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 16.75 +294.1% upside
Now 4.25
- Target (low)
- 9.50
- Target (mean)
- 16.75
- Target (high)
- 21.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.34 | -0.34 – -0.34 | -0.4802 | +29.2% | 83.33K | 0.0% | 2 |
| Next quarter | -0.385 | -0.39 – -0.38 | -0.5227 | +26.3% | 125.00K | 0.0% | 2 |
| Current year | -1.56 | -1.57 – -1.55 | -1.94 | +19.5% | 83.33K | -97.6% | 2 |
| Next year | -1.13 | -1.20 – -1.05 | -1.56 | +27.9% | 18.81M | +22478.5% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 29, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 3, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| May 30, 2024 | Stifel | Initiated | — | Buy |
| May 16, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Apr 23, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 24, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 13, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 24, 2023 | Alliance Global Partners | Reiterated | — | Buy |
| Nov 14, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Nov 8, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| Aug 11, 2022 | SVB Leerink | Maintained | — | Market Perform |